According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:
1. Nutex Health (NASDAQ:NUTX)
Nutex Health (NASDAQ:NUTX) is the #1 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Nutex Health (NASDAQ:NUTX) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: F, Financials: B, and AI: C.
Nutex Health (NASDAQ:NUTX) has a Due Diligence Score of 51, which is 23 points higher than the health information service industry average of 28.
NUTX passed 16 out of 33 due diligence checks and has strong fundamentals. Nutex Health has seen its stock return 210.89% over the past year, overperforming other health information service stocks by 240 percentage points.
Nutex Health has an average 1 year
price target of $205.00, an upside of 37.78% from Nutex Health's current stock price of $148.79.
Nutex Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nutex Health, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Optimizerx (NASDAQ:OPRX)
Optimizerx (NASDAQ:OPRX) is the #2 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.
Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 27, which is -1 points lower than the health information service industry average of 28. Although this number is below the industry average, our proven quant model rates OPRX as a "A".
OPRX passed 8 out of 33 due diligence checks and has average fundamentals. Optimizerx has seen its stock return 88.44% over the past year, overperforming other health information service stocks by 117 percentage points.
Optimizerx has an average 1 year
price target of $19.67, an upside of 82.78% from Optimizerx's current stock price of $10.76.
Optimizerx stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Optimizerx, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Trubridge (NASDAQ:TBRG)
Trubridge (NASDAQ:TBRG) is the #3 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: B, Growth: B, Momentum: D, Sentiment: C, Safety: B, Financials: B, and AI: C.
Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 32, which is 4 points higher than the health information service industry average of 28.
TBRG passed 12 out of 38 due diligence checks and has average fundamentals. Trubridge has seen its stock lose -21.34% over the past year, overperforming other health information service stocks by 7 percentage points.
Trubridge has an average 1 year
price target of $23.00, an upside of 18.86% from Trubridge's current stock price of $19.35.
Trubridge stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Trubridge, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
